Neuropharmacological properties of Su17595A a chlorpromazine-like central nervous system depressant.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001933:Brain Stem / Q000187:drug effects; D002110:Caffeine / Q000037:antagonists & inhibitors; D002415:Cats; D002707:Chlordiazepoxide / Q000008:administration & dosage; D002746:Chlorpromazine / Q000008:administration & dosage; D003042:Cocaine / Q000037:antagonists & inhibitors; D003864:Depression, Chemical; D003913:Dextroamphetamine / Q000037:antagonists & inhibitors; D004336:Drug Antagonism; D006993:Hypnotics and Sedatives / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D051379:Mice; D009020:Morphine / Q000037:antagonists & inhibitors; D009025:Morpholines / Q000494:pharmacology*; D009043:Motor Activity / Q000187:drug effects; D010433:Pentylenetetrazole; D010879:Piperazines / Q000494:pharmacology; D011427:Propiophenones / Q000494:pharmacology; D051381:Rats; D012018:Reflex / Q000187:drug effects; D012119:Respiration / Q000187:drug effects; D012640:Seizures / Q000188:drug therapy; D013331:Strychnine; D014149:Tranquilizing Agents / Q000008:administration & dosage / Q000494:pharmacology*
D006993:Hypnotics and Sedatives; D009025:Morpholines; D010879:Piperazines; D011427:Propiophenones; D014149:Tranquilizing Agents; D002110:Caffeine; D002707:Chlordiazepoxide; D009020:Morphine; D013331:Strychnine; D003042:Cocaine; D003913:Dextroamphetamine; D002746:Chlorpromazine; D010433:Pentylenetetrazole